| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D IQGAP2 ADGRB3 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F NCKAP1L | 1.11e-09 | 279 | 118 | 14 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D IQGAP2 OBSCN ADGRB3 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F NCKAP1L | 3.14e-07 | 507 | 118 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D IQGAP2 OBSCN ADGRB3 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F NCKAP1L | 3.14e-07 | 507 | 118 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D IQGAP2 ADGRB3 TBC1D3C TBC1D3B PTPA BRPF1 TBC1D3I TBC1D3G TBC1D3K TBC1D3F NCKAP1L | 1.59e-06 | 656 | 118 | 16 | GO:0008047 |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D IQGAP2 OBSCN ADGRB3 ELP3 TBC1D3C TBC1D3B NCOR1 PTPA BRPF1 WFIKKN2 TBC1D3I TBC1D3G MTMR9 TBC1D3K TBC1D3F NCKAP1L | 7.98e-05 | 1418 | 118 | 21 | GO:0030234 |
| GeneOntologyMolecularFunction | molecular function activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D IQGAP2 PENK ADGRB3 TBC1D3C TBC1D3B PTPA BRPF1 TBC1D3I TBC1D3G CX3CL1 TBC1D3K TBC1D3F NCKAP1L | 3.27e-04 | 1233 | 118 | 18 | GO:0140677 |
| GeneOntologyMolecularFunction | glucokinase activity | 3.42e-04 | 5 | 118 | 2 | GO:0004340 | |
| GeneOntologyMolecularFunction | hexokinase activity | 3.42e-04 | 5 | 118 | 2 | GO:0004396 | |
| GeneOntologyMolecularFunction | fructokinase activity | 3.42e-04 | 5 | 118 | 2 | GO:0008865 | |
| GeneOntologyMolecularFunction | WD40-repeat domain binding | 5.11e-04 | 6 | 118 | 2 | GO:0071987 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D CORO1C TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.37e-12 | 109 | 118 | 12 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D CORO1C NCSTN ACVR1C TBC1D3C TBC1D3B PTPA SYK TBC1D3I TBC1D3G CX3CL1 MTMR9 TBC1D3K TBC1D3F | 5.00e-10 | 499 | 118 | 18 | GO:0051345 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D CORO1C TBC1D3C TBC1D3B TBC1D3I TBC1D3G CX3CL1 TBC1D3K TBC1D3F | 1.50e-09 | 244 | 118 | 13 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D IQGAP2 CORO1C TBC1D3C TBC1D3B TBC1D3I TBC1D3G CX3CL1 TBC1D3K TBC1D3F | 7.73e-09 | 335 | 118 | 14 | GO:0043087 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D IQGAP2 CORO1C NCSTN ACVR1C TBC1D3C TBC1D3B PTPA WFIKKN2 SYK TBC1D3I TBC1D3G CX3CL1 MTMR9 TBC1D3K TBC1D3F NCKAP1L | 2.44e-08 | 878 | 118 | 21 | GO:0051336 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D CORO1C NCSTN ACVR1C TBC1D3C TBC1D3B PTPA SYK TBC1D3I TBC1D3G CX3CL1 MTMR9 TBC1D3K TBC1D3F | 2.17e-05 | 1028 | 118 | 18 | GO:0043085 |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 9.63e-05 | 42 | 118 | 4 | GO:0031114 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | TBC1D3E TBC1D3 TBC1D3H TBC1D3L NEDD4L TBC1D3D CORO1C NCSTN ACVR1C TBC1D3C TBC1D3B PTPA SYK SMARCA4 TBC1D3I TBC1D3G CX3CL1 MTMR9 TBC1D3K TBC1D3F | 1.69e-04 | 1430 | 118 | 20 | GO:0044093 |
| GeneOntologyBiologicalProcess | cellular component disassembly | HK2 MAP1A MAP1B EML4 ADGRB3 HUWE1 ACVR1C MAP1S SMARCA4 CDK1 MMP19 CX3CL1 | 2.20e-04 | 617 | 118 | 12 | GO:0022411 |
| GeneOntologyBiologicalProcess | NADH regeneration | 2.25e-04 | 21 | 118 | 3 | GO:0006735 | |
| GeneOntologyBiologicalProcess | canonical glycolysis | 2.25e-04 | 21 | 118 | 3 | GO:0061621 | |
| GeneOntologyBiologicalProcess | glucose catabolic process to pyruvate | 2.25e-04 | 21 | 118 | 3 | GO:0061718 | |
| GeneOntologyBiologicalProcess | hexose catabolic process | 2.40e-04 | 53 | 118 | 4 | GO:0019320 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 6.04e-06 | 7 | 118 | 3 | GO:0070776 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 9.62e-06 | 8 | 118 | 3 | GO:0070775 | |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.23e-13 | 49 | 114 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 7.51e-13 | 53 | 114 | 10 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.12e-12 | 55 | 114 | 10 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.12e-12 | 55 | 114 | 10 | PS50086 |
| Domain | MAP1 | 2.21e-07 | 3 | 114 | 3 | IPR026074 | |
| Domain | Trimer_CC | 7.61e-06 | 7 | 114 | 3 | IPR015049 | |
| Domain | DUF1899 | 7.61e-06 | 7 | 114 | 3 | IPR015048 | |
| Domain | Trimer_CC | 7.61e-06 | 7 | 114 | 3 | PF08954 | |
| Domain | DUF1899 | 7.61e-06 | 7 | 114 | 3 | PF08953 | |
| Domain | Coronin | 7.61e-06 | 7 | 114 | 3 | IPR015505 | |
| Domain | DUF1899 | 7.61e-06 | 7 | 114 | 3 | SM01166 | |
| Domain | - | 2.34e-04 | 20 | 114 | 3 | 3.60.15.10 | |
| Domain | Metallo-B-lactamas | 2.34e-04 | 20 | 114 | 3 | IPR001279 | |
| Domain | EPHD | 3.13e-04 | 22 | 114 | 3 | PS51805 | |
| Domain | PWWP | 3.59e-04 | 23 | 114 | 3 | PF00855 | |
| Domain | PWWP_dom | 3.59e-04 | 23 | 114 | 3 | IPR000313 | |
| Domain | Hexokinase_2 | 3.65e-04 | 5 | 114 | 2 | PF03727 | |
| Domain | Hexokinase_BS | 3.65e-04 | 5 | 114 | 2 | IPR019807 | |
| Domain | Hexokinase_C | 3.65e-04 | 5 | 114 | 2 | IPR022673 | |
| Domain | Hexokinase_N | 3.65e-04 | 5 | 114 | 2 | IPR022672 | |
| Domain | Hexokinase_1 | 3.65e-04 | 5 | 114 | 2 | PF00349 | |
| Domain | HEXOKINASE_2 | 3.65e-04 | 5 | 114 | 2 | PS51748 | |
| Domain | HEXOKINASE_1 | 3.65e-04 | 5 | 114 | 2 | PS00378 | |
| Domain | PWWP | 4.08e-04 | 24 | 114 | 3 | PS50812 | |
| Domain | WD40_repeat_dom | 4.77e-04 | 297 | 114 | 8 | IPR017986 | |
| Domain | Bromodomain_CS | 5.20e-04 | 26 | 114 | 3 | IPR018359 | |
| Domain | Hexokinase | 5.45e-04 | 6 | 114 | 2 | IPR001312 | |
| Domain | - | 1.00e-03 | 333 | 114 | 8 | 2.130.10.10 | |
| Domain | EPL1 | 1.01e-03 | 8 | 114 | 2 | PF10513 | |
| Domain | Enhancer_polycomb-like_N | 1.01e-03 | 8 | 114 | 2 | IPR019542 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.04e-03 | 335 | 114 | 8 | IPR015943 | |
| Domain | BROMODOMAIN_1 | 1.48e-03 | 37 | 114 | 3 | PS00633 | |
| Domain | Bromodomain | 1.60e-03 | 38 | 114 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.99e-03 | 41 | 114 | 3 | PS50014 | |
| Domain | Bromodomain | 2.14e-03 | 42 | 114 | 3 | IPR001487 | |
| Domain | BROMO | 2.14e-03 | 42 | 114 | 3 | SM00297 | |
| Domain | - | 2.14e-03 | 42 | 114 | 3 | 1.20.920.10 | |
| Domain | PHD | 2.16e-03 | 89 | 114 | 4 | SM00249 | |
| Domain | Znf_PHD | 2.34e-03 | 91 | 114 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.74e-03 | 95 | 114 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 2.84e-03 | 96 | 114 | 4 | PS01359 | |
| Domain | SANT | 3.52e-03 | 50 | 114 | 3 | SM00717 | |
| Domain | SANT/Myb | 3.94e-03 | 52 | 114 | 3 | IPR001005 | |
| Domain | WD40 | 5.15e-03 | 259 | 114 | 6 | PF00400 | |
| Domain | WD40 | 6.06e-03 | 268 | 114 | 6 | SM00320 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K | 9.37e-09 | 99 | 87 | 9 | M46448 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 5.67e-28 | 11 | 121 | 11 | 16863688 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | TBC1D3E FOXK2 TBC1D3 TBC1D3H TBC1D3D TBC1D3B CORO6 TBC1D3G TBC1D3F | 5.04e-12 | 74 | 121 | 9 | 16625196 |
| Pubmed | HK2 MAP1A EML4 PSMB3 NCSTN HUWE1 DDB1 LAP3 NSDHL OXCT1 EIF3L SLC25A11 BAG6 HDLBP | 5.77e-09 | 534 | 121 | 14 | 35032548 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | MAP1A MAP1B IQGAP2 CORO1C HUWE1 MORC2 CMAS LAP3 NSDHL OXCT1 MAP1S EIF3L SMARCA4 SLC25A11 CDK1 | 2.52e-08 | 704 | 121 | 15 | 29955894 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HK2 TCF20 MAP1B EML4 CORO1C PSMB3 HUWE1 HNRNPUL1 CMAS ELP3 DDB1 OXCT1 ADSS2 EIF3L SMARCA4 SLC25A11 CDK1 CDC5L BAG6 HDLBP | 4.59e-08 | 1353 | 121 | 20 | 29467282 |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 1.64e-07 | 4 | 121 | 3 | 12359748 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 8406013 | ||
| Pubmed | 2.75e-07 | 253 | 121 | 9 | 29911972 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 12604796 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 8471161 | ||
| Pubmed | HK2 ACADM MAP1B IQGAP2 PSMB3 HUWE1 HNRNPUL1 DDB1 ITPR3 CLPTM1L OXCT1 ADSS2 COG1 EIF3L SLC25A11 ATP13A3 CDK1 CDC5L BAG6 | 5.86e-07 | 1440 | 121 | 19 | 30833792 | |
| Pubmed | HK2 EML4 NCSTN HUWE1 CMAS ITPR3 NCOR1 CLPTM1L CORO1A SGMS1 EIF3L SMARCA4 ATP13A3 CDK1 CDC5L BAG6 NCKAP1L | 6.47e-07 | 1168 | 121 | 17 | 19946888 | |
| Pubmed | Structural and histone binding ability characterizations of human PWWP domains. | 8.15e-07 | 6 | 121 | 3 | 21720545 | |
| Pubmed | 1.35e-06 | 226 | 121 | 8 | 31452512 | ||
| Pubmed | Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes. | 1.42e-06 | 7 | 121 | 3 | 18794358 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KIAA0930 FOXK2 MAPKAPK2 OBSCN HUWE1 REV3L BCL9 ITPR3 CCDC142 ESRP2 NCOR1 TKFC MAP1S FEM1A TIMM22 CRAMP1 | 1.52e-06 | 1105 | 121 | 16 | 35748872 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXK2 HK2 HK3 MAP1B IQGAP2 HUWE1 REV3L MORC2 TRIM29 ELP3 NSDHL ESRP2 NCOR1 SMARCA4 | 1.81e-06 | 857 | 121 | 14 | 25609649 |
| Pubmed | HK2 NEDD4L ACADM MAP1A MAP1B CORO1C ADGRB3 HUWE1 TRIM29 CMAS TENM2 CORO1A OXCT1 MAP1S SLC25A11 HDLBP | 2.25e-06 | 1139 | 121 | 16 | 36417873 | |
| Pubmed | NEDD4L MAP1A MAP1B IQGAP2 CORO1C PSMB3 CMAS ELP3 DDB1 CORO1A MAP1S EIF3L SMARCA4 TOLLIP CORO6 SLC25A11 CDC5L HDLBP | 2.35e-06 | 1431 | 121 | 18 | 37142655 | |
| Pubmed | 2.75e-06 | 334 | 121 | 9 | 30425250 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HK2 ACADM CORO1C PSMB3 HUWE1 HNRNPUL1 ELP3 DDB1 LAP3 TKFC OXCT1 ADSS2 MAP1S EIF3L TOLLIP CDK1 BAG6 HDLBP | 2.97e-06 | 1455 | 121 | 18 | 22863883 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TCF20 EML4 HUWE1 HNRNPUL1 BCL9 MORC2 NCOR1 MAP1S BRPF1 SMARCA4 KAT6B BAG6 HDLBP | 3.21e-06 | 774 | 121 | 13 | 15302935 |
| Pubmed | NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation. | 4.84e-06 | 10 | 121 | 3 | 33058421 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | HK2 ACADM IQGAP2 PSMB3 HUWE1 HNRNPUL1 ELP3 DDB1 NCOR1 MAP1S SMARCA4 SLC25A11 CDK1 CDC5L SKAP2 BAG6 | 7.80e-06 | 1257 | 121 | 16 | 37317656 |
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | 9.97e-06 | 392 | 121 | 9 | 33144569 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | KIAA0930 FOXK2 NEDD4L ACADM MAP1B CORO1C PSMB3 HUWE1 EIF3L PHLPP1 SLC25A11 CDK1 FEM1A BAG6 | 1.11e-05 | 1005 | 121 | 14 | 19615732 |
| Pubmed | RBMXL3 ACADM PSMB3 POTEKP NCSTN HNRNPUL1 EFHB CMAS DDB1 TUBB1 EIF3L SLC25A11 CDK1 CDC5L BAG6 | 1.19e-05 | 1153 | 121 | 15 | 29845934 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 7806212 | ||
| Pubmed | MMP-19 deficiency causes aggravation of colitis due to defects in innate immune cell function. | 1.20e-05 | 2 | 121 | 2 | 26555704 | |
| Pubmed | Regulation of microtubule-associated protein 1B (MAP1B) subunit composition. | 1.20e-05 | 2 | 121 | 2 | 11002287 | |
| Pubmed | Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (Fractalkine). | 1.20e-05 | 2 | 121 | 2 | 16148119 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 31201299 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24333487 | ||
| Pubmed | Data mining analysis of the PP2A cell cycle axis in mesothelioma patients. | 1.20e-05 | 2 | 121 | 2 | 31858592 | |
| Pubmed | Syk regulates multiple signaling pathways leading to CX3CL1 chemotaxis in macrophages. | 1.20e-05 | 2 | 121 | 2 | 21388954 | |
| Pubmed | CDK1-mediated BCL9 phosphorylation inhibits clathrin to promote mitotic Wnt signalling. | 1.20e-05 | 2 | 121 | 2 | 30217955 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 16996626 | ||
| Pubmed | The Serine/Threonine Protein Phosphatase 2A (PP2A) Regulates Syk Activity in Human Platelets. | 1.20e-05 | 2 | 121 | 2 | 33255747 | |
| Pubmed | Neuronal abnormalities in microtubule-associated protein 1B mutant mice. | 1.20e-05 | 2 | 121 | 2 | 8577753 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 2355215 | ||
| Pubmed | The mouse and rat MAP1B genes: genomic organization and alternative transcription. | 1.20e-05 | 2 | 121 | 2 | 9615228 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 9199175 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 28391287 | ||
| Pubmed | FOXK2 TCF20 PSMB3 MORC2 CMAS DDB1 NCOR1 CORO1A PTPA ADSS2 EIF3L SMARCA4 CDK1 CDC5L | 1.23e-05 | 1014 | 121 | 14 | 32416067 | |
| Pubmed | EFCAB5 ACADM HUWE1 LAP3 NSDHL CLPTM1L PTPA TKFC ADSS2 COG1 EIF3L SLC25A11 CDK1 | 1.24e-05 | 878 | 121 | 13 | 37223481 | |
| Pubmed | MAP1A MAP1B CORO1C PSMB3 POTEKP HUWE1 HNRNPUL1 ELP3 DDB1 TUBB1 WDR87 EIF3L SLC25A11 CDK1 CDC5L HDLBP | 1.64e-05 | 1335 | 121 | 16 | 29229926 | |
| Pubmed | 1.66e-05 | 153 | 121 | 6 | 28225217 | ||
| Pubmed | 1.86e-05 | 653 | 121 | 11 | 33742100 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 1.93e-05 | 235 | 121 | 7 | 28378594 | |
| Pubmed | MAP1B CORO1C PSMB3 NCSTN HUWE1 DDB1 CLPTM1L SMARCA4 SLC25A11 CDK1 BAG6 | 1.96e-05 | 657 | 121 | 11 | 36180527 | |
| Pubmed | 2.35e-05 | 437 | 121 | 9 | 20562859 | ||
| Pubmed | MLF2 Negatively Regulates P53 and Promotes Colorectal Carcinogenesis. | 2.41e-05 | 48 | 121 | 4 | 37438558 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CORO1C PSMB3 HUWE1 HNRNPUL1 DDB1 NSDHL CORO1A PTPA ADSS2 BRPF1 SLC25A11 HDLBP | 2.61e-05 | 807 | 121 | 12 | 30575818 |
| Pubmed | A comprehensive family-based replication study of schizophrenia genes. | 2.70e-05 | 17 | 121 | 3 | 23894747 | |
| Pubmed | FOXK2 TCF20 CORO1C PSMB3 HNRNPUL1 BCL9 MORC2 NCOR1 CORO1A SYK SMARCA4 CDK1 BAG6 HDLBP | 3.11e-05 | 1103 | 121 | 14 | 34189442 | |
| Pubmed | The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors. | 3.26e-05 | 350 | 121 | 8 | 26549023 | |
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 3.51e-05 | 258 | 121 | 7 | 21081666 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 26855992 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 37717692 | ||
| Pubmed | Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1. | 3.59e-05 | 3 | 121 | 2 | 20400950 | |
| Pubmed | Coronin 1C harbours a second actin-binding site that confers co-operative binding to F-actin. | 3.59e-05 | 3 | 121 | 2 | 22364218 | |
| Pubmed | FAT10 promotes the progression of bladder cancer by upregulating HK2 through the EGFR/AKT pathway. | 3.59e-05 | 3 | 121 | 2 | 33253711 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 2470876 | ||
| Pubmed | Retinitis pigmentosa 2 pathogenic mutants degrade through BAG6/HUWE1 complex. | 3.59e-05 | 3 | 121 | 2 | 35569519 | |
| Pubmed | Diversity of human copy number variation and multicopy genes. | 3.59e-05 | 3 | 121 | 2 | 21030649 | |
| Pubmed | Cell cycle-dependent regulation of the forkhead transcription factor FOXK2 by CDK·cyclin complexes. | 3.59e-05 | 3 | 121 | 2 | 20810654 | |
| Pubmed | Microtubule-associated proteins, MAP 1A and MAP 1B, interact with F-actin in vitro. | 3.59e-05 | 3 | 121 | 2 | 7908020 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 24664738 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 16478718 | ||
| Pubmed | RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. | 3.59e-05 | 3 | 121 | 2 | 15205320 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 36857592 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 27132509 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 23152929 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HK2 CORO1C HUWE1 HNRNPUL1 DDB1 LAP3 NSDHL CLPTM1L ADSS2 EIF3L SMARCA4 SLC25A11 CDK1 CDC5L BAG6 HDLBP | 3.61e-05 | 1425 | 121 | 16 | 30948266 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 3.82e-05 | 358 | 121 | 8 | 32460013 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | FOXK2 CORO1C HUWE1 MORC2 CMAS DDB1 SMARCA4 SLC25A11 CDK1 CDC5L | 3.88e-05 | 583 | 121 | 10 | 29844126 |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 4.06e-05 | 264 | 121 | 7 | 32814769 | |
| Pubmed | NEDD4L HUWE1 HNRNPUL1 TRIM29 DDB1 NCOR1 EIF3L BRD1 BAG6 HDLBP | 4.35e-05 | 591 | 121 | 10 | 15231748 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FOXK2 MAP1B IQGAP2 CORO1C PSMB3 HUWE1 HNRNPUL1 DDB1 LAP3 EIF3L CDK1 CDC5L BAG6 HDLBP | 4.83e-05 | 1149 | 121 | 14 | 35446349 |
| Pubmed | 5.22e-05 | 21 | 121 | 3 | 12840015 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | ACADM CORO1C HUWE1 HNRNPUL1 LAP3 NSDHL CORO1A EIF3L CDK1 HDLBP | 5.44e-05 | 607 | 121 | 10 | 39147351 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ANPEP IQGAP2 PSMB3 NCSTN HUWE1 NEB DDB1 LAP3 TKFC TOLLIP CDK1 ALOX12 IQCG | 5.59e-05 | 1016 | 121 | 13 | 19056867 |
| Pubmed | HK2 CCDC50 HNRNPUL1 MORC2 NSDHL TMEM147 PHLPP1 ATP13A3 BRD1 TIMM22 BAG6 ALOX12 CRAMP1 MTMR9 HDLBP | 5.98e-05 | 1327 | 121 | 15 | 32694731 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TCF20 NEDD4L MAP1B CORO1C HUWE1 HNRNPUL1 DDB1 ITPR3 SMARCA4 CDK1 CDC5L BAG6 HDLBP | 6.05e-05 | 1024 | 121 | 13 | 24711643 |
| Pubmed | Characterization of MRFAP1 turnover and interactions downstream of the NEDD8 pathway. | 6.91e-05 | 23 | 121 | 3 | 22038470 | |
| Pubmed | Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism. | 7.17e-05 | 4 | 121 | 2 | 25904018 | |
| Pubmed | Mutations in the microtubule-associated protein 1A (Map1a) gene cause Purkinje cell degeneration. | 7.17e-05 | 4 | 121 | 2 | 25788676 | |
| Pubmed | Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion. | 7.17e-05 | 4 | 121 | 2 | 24258712 | |
| Pubmed | High 18F-FDG uptake in PMAH correlated with normal expression of Glut1, HK1, HK2, and HK3. | 7.17e-05 | 4 | 121 | 2 | 25766729 | |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 10461187 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 21880731 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 8175911 | ||
| Pubmed | Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine. | 7.17e-05 | 4 | 121 | 2 | 18330920 | |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 26677226 | ||
| Pubmed | Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail specificity. | 7.17e-05 | 4 | 121 | 2 | 24065767 | |
| Pubmed | ACADM EML4 HUWE1 HNRNPUL1 DDB1 EIF3L SMARCA4 CDK1 CDC5L BAG6 | 8.21e-05 | 638 | 121 | 10 | 33239621 | |
| Pubmed | 9.02e-05 | 67 | 121 | 4 | 29357390 | ||
| Pubmed | 9.51e-05 | 408 | 121 | 8 | 33766124 | ||
| Pubmed | 9.56e-05 | 68 | 121 | 4 | 22779921 | ||
| Pubmed | 9.82e-05 | 304 | 121 | 7 | 32235678 | ||
| Interaction | RMND5A interactions | 8.65e-07 | 174 | 118 | 9 | int:RMND5A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D PSMB3 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 7.52e-15 | 149 | 121 | 12 | chr17q12 |
| Cytoband | 17q12 | 2.71e-07 | 99 | 121 | 6 | 17q12 | |
| GeneFamily | WD repeat domain containing|Coronins | 2.37e-06 | 7 | 75 | 3 | 495 | |
| GeneFamily | PWWP domain containing | 9.98e-05 | 22 | 75 | 3 | 1147 | |
| GeneFamily | WD repeat domain containing | 7.63e-04 | 262 | 75 | 6 | 362 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.38e-03 | 53 | 75 | 3 | 532 | |
| GeneFamily | Aminopeptidases|CD molecules | 2.22e-03 | 17 | 75 | 2 | 104 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.22e-03 | 17 | 75 | 2 | 486 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 1.80e-09 | 90 | 118 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 3.02e-06 | 213 | 118 | 9 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 3.02e-06 | 213 | 118 | 9 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D IQGAP2 TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 3.89e-06 | 281 | 118 | 10 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D IQGAP2 TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 3.89e-06 | 281 | 118 | 10 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 8.50e-06 | 242 | 118 | 9 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.68e-05 | 201 | 118 | 8 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | AHI1 NEDD4L MAP1B IQGAP2 CCDC50 HUWE1 REV3L BCL9 TRIM29 TENM2 ESRP2 FEZ1 ATP13A3 ALOX12 HDLBP | 4.09e-05 | 806 | 118 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500 | 7.43e-05 | 78 | 118 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 7.60e-05 | 320 | 118 | 9 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | NEDD4L MAP1B IQGAP2 HUWE1 REV3L BCL9 TRIM29 TENM2 ESRP2 ATP13A3 | 9.28e-05 | 407 | 118 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_200 | 1.32e-04 | 88 | 118 | 5 | gudmap_developingKidney_e15.5_200_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | AHI1 MAP1B IQGAP2 PENK CCDC50 HUWE1 REV3L BCL9 TENM2 ESRP2 NCOR1 DCLK3 ATP13A3 HDLBP | 1.35e-04 | 795 | 118 | 14 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_200 | 2.31e-04 | 54 | 118 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_200_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 3.03e-04 | 163 | 118 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.59e-04 | 312 | 118 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | 4.15e-04 | 402 | 118 | 9 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.19e-04 | 63 | 118 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k3 | |
| ToppCell | MS-IIF-Myeloid-pDC|IIF / Disease, condition lineage and cell class | 1.23e-06 | 199 | 121 | 7 | e262ee854e64d87460bee810c14d6cbe744460e8 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 1.39e-05 | 191 | 121 | 6 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.43e-05 | 192 | 121 | 6 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.47e-05 | 193 | 121 | 6 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | VE-pDC-|VE / Condition, Cell_class and T cell subcluster | 1.47e-05 | 193 | 121 | 6 | 583724de588fcde3aeda056138c522dc0225a387 | |
| ToppCell | VE-pDC|VE / Condition, Cell_class and T cell subcluster | 1.47e-05 | 193 | 121 | 6 | bb759dc9ef0ec41d655002f59021d62d62d44289 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.56e-05 | 195 | 121 | 6 | 06051de72b5c1e0d483a28b14dabd247dfca0ed9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.56e-05 | 195 | 121 | 6 | 3aa44633c72658545aa2b35bf9d532c62f36a451 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 1.56e-05 | 195 | 121 | 6 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 195 | 121 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.65e-05 | 197 | 121 | 6 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.70e-05 | 198 | 121 | 6 | ab70bf89690410221ec7aa3149bb50ac34433f99 | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-pDC|Bac-SEP / Disease, condition lineage and cell class | 1.75e-05 | 199 | 121 | 6 | 7f6569de050262f3d8d9d41c0f0cc139de85c0cb | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 2.09e-05 | 122 | 121 | 5 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-05 | 159 | 121 | 5 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-05 | 159 | 121 | 5 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-05 | 159 | 121 | 5 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.62e-05 | 160 | 121 | 5 | 830e3ef8c9708d25872c3052a0b2682fa9372111 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.62e-05 | 160 | 121 | 5 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.62e-05 | 160 | 121 | 5 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 8.08e-05 | 162 | 121 | 5 | b115b5799137122bd60696f8ae2aebadad6cd044 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.31e-05 | 163 | 121 | 5 | 6b11a3ada8725670d0489f404c8c2175ad3904e9 | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 9.86e-05 | 169 | 121 | 5 | 71f6761b9927f352e0ccc221ca373319915f4184 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 170 | 121 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 171 | 121 | 5 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 171 | 121 | 5 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 174 | 121 | 5 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-04 | 175 | 121 | 5 | 37c2d4e0b6e9a3171931797ce9a54f3347288e57 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 1.16e-04 | 175 | 121 | 5 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 176 | 121 | 5 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 177 | 121 | 5 | 7bc92314b22a876296a4e2db51e7fb0fdfd69379 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 177 | 121 | 5 | 3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d | |
| ToppCell | metastatic_Brain-Myeloid_cells-Activated_DCs|metastatic_Brain / Location, Cell class and cell subclass | 1.22e-04 | 177 | 121 | 5 | 739496fcc4156f4d5e3de9cd21cf3856037f0678 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 178 | 121 | 5 | 01c90c3952220cc4d6a7ed9c4d575fe4f2f80fd1 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-04 | 179 | 121 | 5 | 33ed9270d257895ff3b40df2c1af878119c9f492 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-04 | 179 | 121 | 5 | b7a2429d07d7146b32b3552a5f2a2542105a71e0 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-04 | 179 | 121 | 5 | ce95b601bf17ae8167d382a105384b9e65e9407f | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|tumor_Lung / Location, Cell class and cell subclass | 1.36e-04 | 181 | 121 | 5 | c864ffeb9234b8c29754afc91c85a972889617f4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 182 | 121 | 5 | 4234d0cc57b5266a5e03133c75c7918abe48465e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-pDC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 182 | 121 | 5 | 02c0824373a0ecebc922d4ca848ace9d570722c4 | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|World / Lineage, cell class and subclass | 1.47e-04 | 184 | 121 | 5 | 11619778bc773ecd1a9867330be04deaf324f31e | |
| ToppCell | (7)_MNP-(7)_DC_plasmacytoid|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.51e-04 | 185 | 121 | 5 | 9f67f652488e17075a372e2a2e1100f6d0af6d7d | |
| ToppCell | Bac-SEP-Myeloid-pDC|Bac-SEP / Disease, Lineage and Cell Type | 1.51e-04 | 185 | 121 | 5 | 3de50b2042f22b0fb62ff12c76d85cc67649a0bd | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.51e-04 | 185 | 121 | 5 | 3091870a5bf8ecb963e560b47c8502bae367416c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 186 | 121 | 5 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.54e-04 | 186 | 121 | 5 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-04 | 186 | 121 | 5 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.54e-04 | 186 | 121 | 5 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | wk_08-11-Hematologic-Myeloid-DC1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.58e-04 | 187 | 121 | 5 | 2907cc0b8789c5e1468917caa21fa0feb025305e | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-04 | 187 | 121 | 5 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | Leuk-UTI-Myeloid-pDC|Leuk-UTI / Disease, Lineage and Cell Type | 1.58e-04 | 187 | 121 | 5 | e3035b1f65ab12b8f01799b8e5d6633b9b584a06 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-04 | 188 | 121 | 5 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 189 | 121 | 5 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 190 | 121 | 5 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.70e-04 | 190 | 121 | 5 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | Control-pDC|Control / Disease condition and Cell class | 1.75e-04 | 191 | 121 | 5 | 543e1437a52d04436862dd1c27b4fae95c44fcc8 | |
| ToppCell | Control-pDC-|Control / Disease condition and Cell class | 1.75e-04 | 191 | 121 | 5 | 1d7b0fae4d114d6db933c18b4eb2066ffa61356d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.83e-04 | 193 | 121 | 5 | 52f5b0fbb8ca706206c65e7edbb1ddbd380aebae | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 1.83e-04 | 193 | 121 | 5 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.83e-04 | 193 | 121 | 5 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | control-pDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.83e-04 | 193 | 121 | 5 | 30a6559c9a9e8941861cb259b4836acccc427e68 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.88e-04 | 194 | 121 | 5 | 3043f6230fa723037c8cf7123f611ae847b39fd4 | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.88e-04 | 194 | 121 | 5 | c25fc353001cdf9fcd772da5a254c857e555eab8 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 194 | 121 | 5 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | Control-Myeloid|Control / Disease state, Lineage and Cell class | 1.92e-04 | 195 | 121 | 5 | 46ce2e403ca5d757e5ba17349b6c7ce5cde1f195 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.97e-04 | 196 | 121 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 1.97e-04 | 196 | 121 | 5 | a753d76d764c181eecb0e17a794a2e7d0ff70136 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.97e-04 | 196 | 121 | 5 | a44a648bf209ce037bfc7b3adfcb220aab60728c | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.02e-04 | 197 | 121 | 5 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | myeloid-pro-pDC|World / Lineage and Cell class | 2.02e-04 | 197 | 121 | 5 | 8918ee006b16f6b86ed33ce1dd5c0f01f51f88f5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-04 | 198 | 121 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.06e-04 | 198 | 121 | 5 | 39e52fcd467b8041da977cfe25764df02a87990a | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Monocytes,_Macrophages|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.06e-04 | 198 | 121 | 5 | b32ca1b5d88b13a39f2cd4e129ea031f97475d29 | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 2.06e-04 | 198 | 121 | 5 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-04 | 198 | 121 | 5 | 6a4161680b46b2c12353a693c403b5a4bb3da03f | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease, condition lineage and cell class | 2.06e-04 | 198 | 121 | 5 | 033ed362333e1d33f2aeea8da5865d2228d154dc | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, condition lineage and cell class | 2.06e-04 | 198 | 121 | 5 | fe8a68bff8c1b9566eee4bfcab564f206a20ae7b | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.11e-04 | 199 | 121 | 5 | d0d286eafe935f9b3aaba5b783e8911251121b4a | |
| ToppCell | Sepsis-Leuk-UTI-Myeloid-pDC|Leuk-UTI / Disease, condition lineage and cell class | 2.11e-04 | 199 | 121 | 5 | 2f8d297afd26ae1e9fb66d8573274452c4133b6c | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, condition lineage and cell class | 2.11e-04 | 199 | 121 | 5 | c10c8c9322cad4996e4aa11a8680e3d781644ace | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.11e-04 | 199 | 121 | 5 | 9314eb9a89407738626a0384884454b5f9031ee7 | |
| ToppCell | distal-2-Hematologic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.11e-04 | 199 | 121 | 5 | 6eb7dc2e170da139f3fb80bed2076d5f7a06b4b2 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM3|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.11e-04 | 199 | 121 | 5 | 30523cf08815ca214877e33a2c52197ff8318557 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.11e-04 | 199 | 121 | 5 | 105709b97c55826a852aed27658e3b4af1738c8a | |
| ToppCell | normal_Lung-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.11e-04 | 199 | 121 | 5 | 2f6074a2fd3323f258be03042f77929640ad0a75 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.11e-04 | 199 | 121 | 5 | 0892957a49304ce4b6daa3657d76d8365ce0dd19 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.11e-04 | 199 | 121 | 5 | b2dc3d0af6ecd3ab01779aaa1f061cb0f941cae8 | |
| ToppCell | distal-3-Hematologic-Alveolar_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.11e-04 | 199 | 121 | 5 | f57ba6c711e16fe46f8ddc70223576906b3a710b | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.11e-04 | 199 | 121 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.11e-04 | 199 | 121 | 5 | 667b8b47a5b388506e3177b46747267fad8024f6 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.11e-04 | 199 | 121 | 5 | 961ad44199871be8e09d31904d383edc865ba262 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease, condition lineage and cell class | 2.11e-04 | 199 | 121 | 5 | 9de61e5189d907cc969ac3043d68204f70acc0bf | |
| ToppCell | Control_saline-Hematopoietic_Myeloid-Dendritic_cells-pDC|Control_saline / Treatment groups by lineage, cell group, cell type | 2.11e-04 | 199 | 121 | 5 | 34b95e27581bb127e0b921e9c068dc094cb86b37 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.11e-04 | 199 | 121 | 5 | dbf0bf09896c46155ae6fbd6307f097799e7e34e | |
| ToppCell | severe_influenza-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 2.11e-04 | 199 | 121 | 5 | b8adbd6ff5e5602259118a69fd7c77e8348a27e4 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.16e-04 | 200 | 121 | 5 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-04 | 200 | 121 | 5 | a443e475e7a10c26a6173d1af961de6219e0e567 | |
| ToppCell | severe_influenza|World / disease group, cell group and cell class (v2) | 2.16e-04 | 200 | 121 | 5 | 2c965ec0c33a797c227a06dac90b5ecb959816f6 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.16e-04 | 200 | 121 | 5 | fe27d56a05151049a64e35db5a144ff7952e6902 | |
| ToppCell | Biopsy_Other_PF-Immune|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.16e-04 | 200 | 121 | 5 | 78b35f7afe4a3ebacf115c6d9c873e697bcbd2df | |
| Disease | hyperinsulinemic hypoglycemia (implicated_via_orthology) | 1.34e-04 | 5 | 109 | 2 | DOID:13317 (implicated_via_orthology) | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 2.01e-04 | 6 | 109 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | Periventricular Nodular Heterotopia | 2.81e-04 | 7 | 109 | 2 | C1868720 | |
| Disease | IGF-1 measurement | 4.67e-04 | 488 | 109 | 8 | EFO_0004627 | |
| Disease | underweight body mass index status | 4.79e-04 | 9 | 109 | 2 | EFO_0005936 | |
| Disease | maturity-onset diabetes of the young (implicated_via_orthology) | 5.97e-04 | 10 | 109 | 2 | DOID:0050524 (implicated_via_orthology) | |
| Disease | Congenital myopathy (disorder) | 8.71e-04 | 12 | 109 | 2 | C0270960 | |
| Disease | language measurement | 1.57e-03 | 134 | 109 | 4 | EFO_0007797 | |
| Disease | HETE measurement | 1.58e-03 | 62 | 109 | 3 | EFO_0801166 | |
| Disease | hyperglycemia (implicated_via_orthology) | 1.77e-03 | 17 | 109 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | serum gamma-glutamyl transferase measurement | NEDD4L MAP1A IQGAP2 EML4 CCDC50 TENM2 MAP1S TMEM147 PMFBP1 HDLBP | 2.08e-03 | 914 | 109 | 10 | EFO_0004532 |
| Disease | Malignant neoplasm of breast | HK3 ACADM UBD OBSCN TRIM29 ELP3 NCOR1 CLPTM1L NSUN6 KAT6B HDLBP | 2.10e-03 | 1074 | 109 | 11 | C0006142 |
| Disease | metabolite measurement, diet measurement | 2.34e-03 | 71 | 109 | 3 | EFO_0004725, EFO_0008111 | |
| Disease | CCL4 measurement | 2.46e-03 | 20 | 109 | 2 | EFO_0004751 | |
| Disease | Non-Small Cell Lung Carcinoma | 2.72e-03 | 156 | 109 | 4 | C0007131 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 3.28e-03 | 80 | 109 | 3 | DOID:1459 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SIYGGELGPMMKLKR | 636 | Q5FVE4 | |
| QKAGLYMKMEPVKEL | 356 | O95696 | |
| MIINYGKKMLDITPG | 1226 | Q96N23 | |
| KMKILLGGYQSRAMG | 716 | Q99459 | |
| YEDGGMKPRVMKEAV | 146 | Q8IVM0 | |
| AYLSGMPAKRRKTMQ | 1041 | P46379 | |
| SYRSMMALQEEKGKP | 546 | Q8N157 | |
| TDINFPMKGRKGMVD | 716 | O60242 | |
| VLGDRKMDAYMKGAP | 641 | Q9H7F0 | |
| KRDGPRATMKIMNYD | 141 | Q9HC16 | |
| KRGMLTLKYPMEHGI | 61 | Q9BYX7 | |
| PKVGTKRYMAPEMLD | 361 | Q8NER5 | |
| GMGYMPKRGLDVNKC | 316 | Q9ULV4 | |
| TVHVYPDKMMLKGRG | 311 | Q3LIE5 | |
| HKQAMQGFKLYMPRG | 516 | Q17RM4 | |
| KLMFDRSEVYGPMKN | 706 | P15144 | |
| SSKESQRGMGYMPKR | 311 | P31146 | |
| QKKKYLGRMTEEPLM | 141 | P11310 | |
| GTMIRREIGGFKMPK | 406 | Q9H095 | |
| MVNMVVLGKYLGIPK | 586 | Q9ULC6 | |
| QIPYDKGDAKMMEIL | 1211 | Q14573 | |
| SRMVYDMEKGKFPVQ | 341 | Q92542 | |
| LKEGRQIKPYTLMSM | 76 | P49720 | |
| MLGRLKYKVTPQMGT | 631 | Q8WYB5 | |
| SKEVPEMEKRYGGFM | 251 | P01210 | |
| MTNKDEVPYLRKGMT | 486 | P28838 | |
| PFMLKTLNKLGIDGM | 611 | O00370 | |
| HKMGVGRLDMYVLNP | 191 | P78559 | |
| LFQKMGVGKLEMYVL | 411 | P46821 | |
| EKMGVGRLDMYVLHP | 386 | Q66K74 | |
| ISPGMKTRIRMGQYE | 271 | P49137 | |
| YHKKNGMVIMRSGQP | 191 | Q96QG7 | |
| REKYGDKMLRMQKGD | 391 | Q9Y262 | |
| DKMLRMQKGDPQVYE | 396 | Q9Y262 | |
| GYKVGRVMPSDLNLM | 221 | Q01167 | |
| KPYRGMKGSEVTAML | 571 | P43405 | |
| RKNGMKLEVYPPTMG | 396 | Q8NBH2 | |
| VYMEMEKGDLPTRLK | 821 | Q9UPZ3 | |
| KYSNMEFVRMKGPQG | 236 | Q6ICG6 | |
| MGKGPMYDVEKLVRT | 166 | Q9C098 | |
| LNPGKQLFEKMISGM | 286 | P52789 | |
| PGKQRFEKMISGMYL | 736 | P52789 | |
| MMLGPRGKTYAFKGD | 296 | Q99542 | |
| GDKLYNEARKIMGAM | 411 | P11678 | |
| EMRALAELLGPYGMK | 836 | P55160 | |
| KGNQMPLKRFSMEGI | 306 | Q99689 | |
| GEKQYLAAPLVMLKM | 291 | P18054 | |
| LKGMGIRMTEPVYLS | 191 | Q8TEA1 | |
| NPGKQRFEKMISGMY | 741 | P52790 | |
| PLKVYGGRMAESMLA | 1261 | Q7Z6Z7 | |
| RIQNMRMIDGKPEYK | 246 | Q02978 | |
| AKEEIMKAMTSGYRP | 441 | Q5XG87 | |
| IKMYEKVGPQLEGGM | 391 | Q9Y6X9 | |
| YKVRKEMKQQEGPMF | 4886 | Q5VST9 | |
| IKDPGMSGYQRLMKE | 226 | A4FU69 | |
| MYVKSMKGLAGIRDA | 371 | Q8WTW3 | |
| PMAEKLKEMGISVRG | 176 | Q9BPX7 | |
| KMREAGAGPEEMLKL | 736 | O00512 | |
| LTLAEVYLMMGKPSK | 686 | Q96RY5 | |
| KARMERDGYGMTPLL | 206 | Q9BSK4 | |
| GGKMLDKLRYVFSQM | 141 | O60941 | |
| RGMGFMPKRGLDVSK | 316 | Q6QEF8 | |
| RKIGYRLQGPYMVKM | 531 | Q9H9T3 | |
| GDKRVIMGTKFPMEL | 16 | Q8N7U6 | |
| NQEGEYIKMFMRGRP | 221 | Q9HC35 | |
| RQMKKQDSMLPLGSY | 3466 | Q8NDH2 | |
| GMYGKIAVMELFRPK | 56 | Q16531 | |
| AYRPEMKTEMKQGAP | 136 | Q9BUJ2 | |
| GLPQDMGQRMDLTKY | 981 | Q8TBY8 | |
| YHKDKPGMEQGRLQM | 1556 | Q2WGJ9 | |
| VLYIEGHMNPKMKGF | 441 | Q2TAK8 | |
| SPSYRMDDGKMVKVR | 221 | Q96CM3 | |
| MDSMEGKRSPYAGLQ | 96 | Q14134 | |
| VGLMYTQGPLKKIME | 201 | Q8TEB9 | |
| KRHLIEMGYLQGGKM | 221 | Q8NFW8 | |
| MKGAIGLVPKAYIME | 341 | O75563 | |
| NMRKELEKYGIQMPS | 181 | Q13576 | |
| LLGKYPGRNGAQMMV | 596 | A6NCM1 | |
| NGLMEDPMKVYKDRQ | 421 | O75376 | |
| EKGMSDDPRYNQMKG | 81 | P51532 | |
| MTMPEYLKKRFGGER | 126 | Q9NY91 | |
| GMGTLLMNKIREEYP | 146 | Q9H4B7 | |
| MSPRGIAVDKNGLMY | 1356 | Q9NT68 | |
| ERAKKAMGYQPLVTM | 341 | Q15738 | |
| KGYMEKIKPMVRDGV | 221 | P30520 | |
| KYGDLANWMIPGKMV | 406 | P55809 | |
| VRMQGVPYTAGMKDL | 676 | Q9H6T0 | |
| SRKLIDRAYKGMPMN | 91 | B9A6J9 | |
| QAGLYMKMEPVRETG | 416 | P55201 | |
| KMLIYDPAKRISGKM | 266 | P06493 | |
| PADVHRYMKMIQLGK | 191 | Q96KA5 | |
| REKEYGVKHMPMGNN | 16 | Q8N326 | |
| MLEMEYLRGPKGDTG | 481 | Q17RW2 | |
| KGMDMDPRKALLIVG | 11 | Q96PV4 | |
| SRKLIDRAYKGMPMN | 91 | A6NDS4 | |
| SRKLIDRAYKGMPMN | 91 | P0C7X1 | |
| GKRLEDGKMMADYGI | 136 | O15205 | |
| VEPVRMGEGNMLYKS | 446 | Q13064 | |
| ARDMNGKYLDGKAIM | 66 | Q8N7X1 | |
| GGSQLLFKQKDMPLM | 1256 | O60673 | |
| SRKLIDRAYKGMPMN | 91 | A6NER0 | |
| VMRKLQKTYRMEPAG | 226 | Q15257 | |
| QAKLAKNYGMTRMDP | 61 | Q9H0E2 | |
| KIKPNGMPNGYRKEM | 101 | Q86VZ5 | |
| KQKYGEGLIFLMMLQ | 56 | A0A0B4J273 | |
| SRKLIDQAYKGMPMN | 91 | A0A087X179 | |
| RVRSPLKNDKDGMMY | 1131 | Q9UGU0 | |
| MQRKEMETYLKKIPG | 56 | Q13530 | |
| AKEVLKDMGQRGMSY | 111 | Q9Y584 | |
| GMYNVRKGKMQLPVN | 541 | O60346 | |
| SRKLIDRAYKGMPMN | 91 | A0A087WVF3 | |
| YVIGQKGSGIRKMMD | 986 | Q00341 | |
| LVMSRNAGKGEYKIM | 86 | Q9BVK8 | |
| AMQKYGKAAPGDRTM | 481 | Q3LXA3 | |
| SRKLIDRAYKGMPMN | 91 | Q6DHY5 | |
| SRKLIDRAYKGMPMN | 91 | Q8IZP1 | |
| GTMDKEREVMGKYEP | 2431 | Q6ZQQ6 | |
| SRKLIDRAYKGMPMN | 91 | A0A087X1G2 | |
| SRKLIDRAYKGMPMN | 91 | A0A087WXS9 | |
| SRKLIDRAYKGMPMN | 91 | Q6IPX1 | |
| KMAGEMAEGLRYIPR | 371 | P78423 | |
| ARYMDVKGKKGPVGM | 91 | Q8TEU8 | |
| GLSMLGRPDIEMAKK | 5771 | P20929 | |
| LRLKMAYMPKNGGQD | 146 | Q96PU5 |